Patients Know Best key facts
as of Oct 2026- Developer of a software-as-a-service platform designed to store health information in a single place.
- Patients Know Best is valued at approximately $49.5M as of Oct 2026 (last reported valuation).
- It has raised $46.2M.
- Notable investors include Seedcamp, Caffeinated Capital, Elad Gil, Claret Capital Partners, Esther Dyson — 28 tracked in total.
- Status: Privately Held (backing).
Patients Know Best's last reported valuation, Sep 2025. Nothing priced has surfaced since.
- ·The complete investor list: 28 names
- ·Watch Patients Know Best: the Monday email on marks, rounds and moves
Patients Know Best funding rounds
No funding rounds for Patients Know Best are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Patients Know Best
28+Membership and data by Private Market View
Patients Know Best valuation
Patients Know Best's last reported valuation was $49.5 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
Patients Know Best investors
28 investors are on record for Patients Know Best, including Seedcamp, Caffeinated Capital, Elad Gil and Claret Capital Partners.
About Patients Know Best
Developer of a software-as-a-service platform designed to store health information in a single place. The company's platform collects data from healthcare providers and shares it with patients, carers, and care teams with immediate access to vital information like appointment letters, care plans, medication lists, test results, allergies and details of previous attendances and discharge summaries, enabling patients to take control of their health and physicians to increase the efficiency of communication.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2008
- Employees
- 93
- Website
- patientsknowbest.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.